10-Q Filing

Monte Rosa Therapeutics, Inc. CIK: 1826457 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0000950170-21-001372`
Period End Date	20210630
Filing Date	20210812
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	glue-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 61 Income Statement 60 Cash Flow Statement 64 Stockholders Equity 35

Balance Sheet 61 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, par or stated value per share	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, par or stated value per share	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`TemporaryEquitySharesAuthorized`	77.63M	shares	Point-in-time
Convertible preferred stock, shares authorized	`TemporaryEquitySharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$357.06M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$41.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.71M	USD	Point-in-time
Convertible preferred stock, shares issued	`TemporaryEquitySharesIssued`	53.63M	shares	Point-in-time
Convertible preferred stock, shares issued	`TemporaryEquitySharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.23M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.89M	USD	Point-in-time
Convertible preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	53.63M	shares	Point-in-time
Convertible preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$43.59M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$358.29M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.62M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$8.92M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	97.50M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.16M	USD	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	45.03M	shares	Point-in-time
Common stock, shares, issued	`CommonStockSharesIssued`	2.18M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.73M	USD	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	1.69M	shares	Point-in-time
Total assets	`Assets`	$49.38M	USD	Point-in-time
Common stock shares outstanding	`CommonStockSharesOutstanding`	44.60M	shares	Point-in-time
Total assets	`Assets`	$368.94M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.07M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.33M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.53M	USD	Point-in-time
Preferred stock tranche obligations	`PreferredStockTrancheObligationsCurrent`	$19.68M	USD	Point-in-time
Preferred stock tranche obligations	`PreferredStockTrancheObligationsCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$29.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$10.79M	USD	Point-in-time
Defined benefit plan liability	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$1.07M	USD	Point-in-time
Defined benefit plan liability	`DefinedBenefitPensionPlanLiabilitiesNoncurrent`	$1.47M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.26M	USD	Point-in-time
Total liabilities	`Liabilities`	$30.34M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred stock, $0.0001 par value; no shares authorized, issued and outstanding as of June 30, 2021; and 77,631,514 shares authorized and 53,631,514 shares issued and outstanding as of December 31, 2020	`TemporaryEquityValueExcludingAdditionalPaidInCapital`	-	USD	Point-in-time
Convertible preferred stock, $0.0001 par value; no shares authorized, issued and outstanding as of June 30, 2021; and 77,631,514 shares authorized and 53,631,514 shares issued and outstanding as of December 31, 2020	`TemporaryEquityValueExcludingAdditionalPaidInCapital`	$67.76M	USD	Point-in-time
Common stock, $0.0001 par value; 500,000,000 shares authorized, 45,025,857 shares issued and 44,603,731 shares outstanding as of June 30, 2021; and 97,500,000 shares authorized, 2,180,803 shares issued and 1,685,534 shares outstanding as of December 31, 2020	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock, $0.0001 par value; 500,000,000 shares authorized, 45,025,857 shares issued and 44,603,731 shares outstanding as of June 30, 2021; and 97,500,000 shares authorized, 2,180,803 shares issued and 1,685,534 shares outstanding as of December 31, 2020	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$404.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$436.85M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.42M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-48.08M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-78.76M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-16.44M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$356.68M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-21.71M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-12.15M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-48.73M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-60.62M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$49.38M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$368.94M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$23.91M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.86M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.67M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$14.64M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.49M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.02M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.72M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$541.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$9.69M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$5.40M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$29.63M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$18.12M	USD	1 Quarter
Operating Income (Loss), Total	`OperatingIncomeLoss`	$-18.12M	USD	1 Quarter
Operating Income (Loss), Total	`OperatingIncomeLoss`	$-9.69M	USD	2 Qtrs
Operating Income (Loss), Total	`OperatingIncomeLoss`	$-29.63M	USD	2 Qtrs
Operating Income (Loss), Total	`OperatingIncomeLoss`	$-5.40M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$14.00K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$-2.00K	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$1.00K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNonoperatingNet`	$20.00K	USD	2 Qtrs
Foreign currency exchange gain (loss), net	`ForeignCurrencyTransactionGainLossBeforeTax`	$31.00K	USD	1 Quarter
Foreign currency exchange gain (loss), net	`ForeignCurrencyTransactionGainLossBeforeTax`	$25.00K	USD	2 Qtrs
Foreign currency exchange gain (loss), net	`ForeignCurrencyTransactionGainLossBeforeTax`	$-114.00K	USD	2 Qtrs
Foreign currency exchange gain (loss), net	`ForeignCurrencyTransactionGainLossBeforeTax`	$-296.00K	USD	1 Quarter
Changes in fair value of preferred stock tranche obligations, net	`ChangesInFairValueOfPreferredStockTrancheObligationsNet`	-	USD	1 Quarter
Changes in fair value of preferred stock tranche obligations, net	`ChangesInFairValueOfPreferredStockTrancheObligationsNet`	-	USD	2 Qtrs
Changes in fair value of preferred stock tranche obligations, net	`ChangesInFairValueOfPreferredStockTrancheObligationsNet`	-	USD	1 Quarter
Changes in fair value of preferred stock tranche obligations, net	`ChangesInFairValueOfPreferredStockTrancheObligationsNet`	$-960.00K	USD	2 Qtrs
Total other (expense) income	`NonoperatingIncomeExpense`	$-1.05M	USD	2 Qtrs
Total other (expense) income	`NonoperatingIncomeExpense`	$32.00K	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$-282.00K	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$23.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-18.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-30.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-9.67M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.30M	USD	1 Quarter
Provision for pension benefit obligation	`ProvisionForPensionBenefitObligation`	-	USD	1 Quarter
Provision for pension benefit obligation	`ProvisionForPensionBenefitObligation`	$-359.00K	USD	2 Qtrs
Provision for pension benefit obligation	`ProvisionForPensionBenefitObligation`	-	USD	2 Qtrs
Provision for pension benefit obligation	`ProvisionForPensionBenefitObligation`	$-495.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-18.90M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.67M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.36M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-31.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-18.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-30.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-9.67M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.30M	USD	1 Quarter
Net loss per share attributable to common stockholdersbasic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.63	USD	1 Quarter
Net loss per share attributable to common stockholdersbasic and diluted	`EarningsPerShareBasicAndDiluted`	$-6.69	USD	2 Qtrs
Net loss per share attributable to common stockholdersbasic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.64	USD	1 Quarter
Net loss per share attributable to common stockholdersbasic and diluted	`EarningsPerShareBasicAndDiluted`	$-9.03	USD	2 Qtrs
Weighted-average number of shares outstanding used in computing net loss per common sharebasic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.45M	shares	2 Qtrs
Weighted-average number of shares outstanding used in computing net loss per common sharebasic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.40M	shares	2 Qtrs
Weighted-average number of shares outstanding used in computing net loss per common sharebasic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.48M	shares	1 Quarter
Weighted-average number of shares outstanding used in computing net loss per common sharebasic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.07M	shares	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Proceeds from initial public offering, net of underwriting discount	`ProceedsFromInitialPublicOfferingNetOfUnderwritingDiscount`	$15.60M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-9.67M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-30.68M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$108.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.27M	USD	2 Qtrs
Depreciation	`Depreciation`	$741.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$143.00K	USD	2 Qtrs
Changes in fair value of preferred stock tranche obligations	`ChangesInFairValueOfPreferredStockTrancheObligationsNet`	-	USD	1 Quarter
Changes in fair value of preferred stock tranche obligations	`ChangesInFairValueOfPreferredStockTrancheObligationsNet`	-	USD	2 Qtrs
Changes in fair value of preferred stock tranche obligations	`ChangesInFairValueOfPreferredStockTrancheObligationsNet`	-	USD	1 Quarter
Changes in fair value of preferred stock tranche obligations	`ChangesInFairValueOfPreferredStockTrancheObligationsNet`	$-960.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-663.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$522.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.20M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.16M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$191.00K	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$844.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.59M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-27.40M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.27M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.92M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.92M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.27M	USD	2 Qtrs
Proceeds from issuance of convertible preferred stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$12.50M	USD	2 Qtrs
Proceeds from issuance of convertible preferred stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$143.00M	USD	2 Qtrs
Payment of convertible preferred stock issuance costs	`PaymentsOfStockIssuanceCosts`	$231.00K	USD	2 Qtrs
Payment of convertible preferred stock issuance costs	`PaymentsOfStockIssuanceCosts`	$178.00K	USD	2 Qtrs
Proceeds from initial public offering, net of underwriting discount of $15.6 million	`ProceedsFromIssuanceInitialPublicOffering`	$206.74M	USD	2 Qtrs
Proceeds from initial public offering, net of underwriting discount of $15.6 million	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	2 Qtrs
Payment of initial public offering issuance costs	`PaymentsForRepurchaseOfInitialPublicOffering`	-	USD	2 Qtrs
Payment of initial public offering issuance costs	`PaymentsForRepurchaseOfInitialPublicOffering`	$1.40M	USD	2 Qtrs
Proceeds from exercise of employee stock options	`ProceedsFromStockOptionsExercised`	$128.00K	USD	2 Qtrs
Proceeds from exercise of employee stock options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$348.24M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$12.32M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.46M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$315.93M	USD	2 Qtrs
Cash, cash equivalents and restricted cashbeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.71M	USD	Point-in-time
Cash, cash equivalents and restricted cashbeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$358.79M	USD	Point-in-time
Cash, cash equivalents and restricted cashbeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.86M	USD	Point-in-time
Cash, cash equivalents and restricted cashbeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.24M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.71M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$358.79M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.86M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.24M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$357.06M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$41.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.71M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$1.73M	USD	Point-in-time
Restricted cash	`RestrictedCash`	-	USD	Point-in-time
Cash, cash equivalents and restricted cashend of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.71M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$358.79M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.86M	USD	Point-in-time
Cash, cash equivalents and restricted cashend of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.24M	USD	Point-in-time
Conversion of convertible preferred stock into common stock	`ConversionOfConvertiblePreferredStockIntoCommonStock`	$231.17M	USD	2 Qtrs
Conversion of convertible preferred stock into common stock	`ConversionOfConvertiblePreferredStockIntoCommonStock`	-	USD	2 Qtrs
Settlement of preferred stock tranche obligation	`SettlementOfPreferredStockTrancheObligation`	$20.64M	USD	2 Qtrs
Settlement of preferred stock tranche obligation	`SettlementOfPreferredStockTrancheObligation`	-	USD	2 Qtrs
Common stock issuance costs in accounts payable	`CommonStockIssuanceCostsInAccountsPayable`	-	USD	2 Qtrs
Common stock issuance costs in accounts payable	`CommonStockIssuanceCostsInAccountsPayable`	$1.47M	USD	2 Qtrs
Conversion of convertible note payable and accrued interest into Series A convertible preferred stock	`ConversionOfConvertibleNotePayableAndAccruedInterestIntoSeriesAConvertiblePreferredStock`	-	USD	2 Qtrs
Conversion of convertible note payable and accrued interest into Series A convertible preferred stock	`ConversionOfConvertibleNotePayableAndAccruedInterestIntoSeriesAConvertiblePreferredStock`	$754.00K	USD	2 Qtrs
Purchases of property and equipment in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$123.00K	USD	2 Qtrs
Purchases of property and equipment in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$332.00K	USD	2 Qtrs

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Stock issuance costs	`PaymentsOfStockIssuanceCosts`	$231.00K	USD	2 Qtrs
Stock issuance costs	`PaymentsOfStockIssuanceCosts`	$178.00K	USD	2 Qtrs
Balance	`StockholdersEquity`	$-16.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$356.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$-21.71M	USD	Point-in-time
Balance	`StockholdersEquity`	$-12.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$-48.73M	USD	Point-in-time
Balance	`StockholdersEquity`	$-60.62M	USD	Point-in-time
Balance (in shares)	`TemporaryEquitySharesOutstanding`	53.63M	shares	Point-in-time
Balance (in shares)	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time
Exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$128.00K	USD	1 Quarter
Exercise of common stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	76,950.00	shares	2 Qtrs
Issuance of common stock	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	1 Quarter
Issuance of common stock in connection with initial public offering, net of issuance costs of $18.5 million	`StockIssuedDuringPeriodValueNewIssues`	$203.88M	USD	1 Quarter
Issuance of convertible preferred stock, net of issuance costs	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$231.17M	USD	1 Quarter
Provision for pension benefit obligation	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$136.00K	USD	1 Quarter
Provision for pension benefit obligation	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-495.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$252.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.02M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$97.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-18.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.28M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-30.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-9.67M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.30M	USD	1 Quarter
Balance	`StockholdersEquity`	$-16.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$356.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$-21.71M	USD	Point-in-time
Balance	`StockholdersEquity`	$-12.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$-48.73M	USD	Point-in-time
Balance	`StockholdersEquity`	$-60.62M	USD	Point-in-time
Balance (in shares)	`TemporaryEquitySharesOutstanding`	53.63M	shares	Point-in-time
Balance (in shares)	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.